Please assess the completion status of the following clinical trial:

Trial Title: Differential Efficacy of Corticosteroid Solutions for Non-Operative Treatment of Digit Flexor Tenosynovitis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~1. Adults aged 18 years and older~2. At least one symptomatic trigger finger~3. Patients recommended to receive corticosteroid injections~Exclusion Criteria:~1. Previous surgeries/injections for trigger fingers in digit being treated for study~2. Participating in another clinical trial~3. Inability to receive corticosteroid injections (i.e. allergies, adverse reactions, etc.)~4. Unable to sign informed consent~5. Pregnant or plan to become pregnant

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Triamcinolone 40mg/mL (Type: ACTIVE_COMPARATOR): A corticosteroid injection of Triamcinolone 40mg/mL will be given to subjects to treat their symptoms of trigger finger.
- Triamcinolone 10mg/mL (Type: ACTIVE_COMPARATOR): A corticosteroid injection of Triamcinolone 10mg/mL will be given to subjects to treat their symptoms of trigger finger.
- Soluble dexamethasone 4mg/mL (Type: ACTIVE_COMPARATOR): A corticosteroid injection of Soluble Dexamethasone 4mg/mL will be given to subjects to treat their symptoms of trigger finger.

Based on this trial design, predict the completion outcome and termination type (if applicable).